About Harbin Medisan Pharmaceutical Company

The company is a listed pharmaceutical company with multiple varieties and multiple dosage forms for domestic and foreign markets, and is a high-tech enterprise. The company was founded in 1996. In 2001, freeze-dried powders, small-volume injections, and large-volume injections passed national GMP certification at one time. The company's production capacity was rapidly improved, and economic efficiency improved rapidly. Since 2011, the company has sought prosperity and development based on group chemical operations, completed the shareholding system reform in 2013, and was successfully listed on the Shenzhen Stock Exchange on September 22, 2017. The company is mainly engaged in chemical R&D, production and sales. The main products are mirtazapine tablets, injectable yanhuning, injectable esprolol hydrochloride, injectable ceftiafil sodium, injectable ampicillin sodium, injectable penicillin sodium, injectable streptomycin sulfate, lincomycin hydrochloride injection, flunisine glucamine injection, dexmetomidine hydrochloride injection, acetaminophen diclofenac sodium injection, sodium hyaluronate repair patch, astaxanthin collagen peptide nano-emulsified drink (good beauty), SOD enzyme activity Milk thistle nano-emulsified drink (easy to dry), high-purity deep-sea fish oil nano emulsified drink (good nutrition), gamma-aminobutyric acid Nano emulsified drink (good sleep), Kazanlian sodium hyaluronate repair film. Corporate honors: Sodium Ferulate for cardiovascular injections was awarded the first prize for scientific and technological progress in the pharmaceutical industry in Heilongjiang Province; the company paid taxes in good faith, made outstanding contributions, and was included in the “National Qianhu Group Headquarters Enterprise” by the State Administration of Taxation; deepening its brand development strategy, Harbin Sanlian was awarded the honorary titles of “2018 China's Top 20 Companies with Brand Value of 100 Million Yuan”; in the first half of 2019, with R&D innovation and professional promotion advantages, Harbin Sanlian was awarded the honorary titles of “2018 China's Top 100 Chemical Companies” 64th place, Top 50 private enterprises in Harbin in 2023, national intellectual property demonstration enterprises in 2022.